Work

Phase II Trial of Temozolomide and Irinotecan as Second-Line Treatment for Advanced Non–small Cell Lung Cancer

Year: 2006

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/s1556-0864(15)31575-6

Authors: Nicholas W. Choong, Ann M. Mauer, Philip C. Hoffman, Charles M. Rudin, Jerome D. Winegarden, J Lee Villano, Mark Kozloff, James L. Wade, David F. Sciortino, Livia Szeto, Everett E. Vokes

Institutions: University of Chicago Medical Center, University of Chicago, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Trinity Health Ann Arbor Hospital, Ingalls Memorial Hospital, Decatur Memorial Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

OpenAlex ID: W2201607481

FWCI: 1.609

Cites: 47

Cited by: 21

Related to: 10